Found: 27
Select item for more details and to access through your institution.
Evaluating pediatric tuberculosis dosing guidelines: A model-based individual data pooled analysis.
- Published in:
- PLoS Medicine, 2023, v. 20, n. 11, p. 1, doi. 10.1371/journal.pmed.1004303
- By:
- Publication type:
- Article
Extrahepatic metabolism of ibrutinib.
- Published in:
- Investigational New Drugs, 2021, v. 39, n. 1, p. 1, doi. 10.1007/s10637-020-00970-x
- By:
- Publication type:
- Article
First Pharmacokinetic Data of Tenofovir Alafenamide Fumarate and Tenofovir With Dolutegravir or Boosted Protease Inhibitors in African Children: A Substudy of the CHAPAS-4 Trial.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, n. 6, p. 875, doi. 10.1093/cid/ciad267
- By:
- Publication type:
- Article
Optimizing Dosing and Fixed-Dose Combinations of Rifampicin, Isoniazid, and Pyrazinamide in Pediatric Patients With Tuberculosis: A Prospective Population Pharmacokinetic Study.
- Published in:
- Clinical Infectious Diseases, 2022, v. 75, n. 1, p. 141, doi. 10.1093/cid/ciab908
- By:
- Publication type:
- Article
Fixed Dosing of Liposomal Amphotericin B in Morbidly Obese Individuals.
- Published in:
- Clinical Infectious Diseases, 2020, v. 79, n. 10, p. 2213, doi. 10.1093/cid/ciz885
- By:
- Publication type:
- Article
Pharmacogenetics of Dolutegravir Plasma Exposure Among Southern Africans With Human Immunodeficiency Virus.
- Published in:
- 2022
- By:
- Publication type:
- journal article
A Nanopore Sequencing-based Pharmacogenomic Panel to Personalize Tuberculosis Drug Dosing.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2024, v. 209, n. 12, p. 1486, doi. 10.1164/rccm.202309-1583OC
- By:
- Publication type:
- Article
A model-based approach for a practical dosing strategy for the short, intensive treatment regimen for paediatric tuberculous meningitis.
- Published in:
- Frontiers in Pharmacology, 2023, p. 1, doi. 10.3389/fphar.2023.1055329
- By:
- Publication type:
- Article
Correction to: Tobramycin Clearance Is Best Described by Renal Function Estimates in Obese and Nonobese Individuals: Results of a Prospective Rich Sampling Pharmacokinetic Study.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Tobramycin Clearance Is Best Described by Renal Function Estimates in Obese and Non-obese Individuals: Results of a Prospective Rich Sampling Pharmacokinetic Study.
- Published in:
- Pharmaceutical Research, 2019, v. 36, n. 8, p. N.PAG, doi. 10.1007/s11095-019-2651-2
- By:
- Publication type:
- Article
Normal fat mass cannot be reliably estimated in typical pharmacokinetic studies.
- Published in:
- European Journal of Clinical Pharmacology, 2021, v. 77, n. 5, p. 727, doi. 10.1007/s00228-020-03042-4
- By:
- Publication type:
- Article
Ciprofloxacin Pharmacokinetics After Oral and Intravenous Administration in (Morbidly) Obese and Non-obese Individuals: A Prospective Clinical Study.
- Published in:
- Clinical Pharmacokinetics, 2022, v. 61, n. 8, p. 1167, doi. 10.1007/s40262-022-01130-5
- By:
- Publication type:
- Article
Determinants of early change in serum creatinine after initiation of dolutegravir‐based antiretroviral therapy in South Africa.
- Published in:
- British Journal of Clinical Pharmacology, 2024, v. 90, n. 5, p. 1247, doi. 10.1111/bcp.16009
- By:
- Publication type:
- Article
Drug–drug interaction between rifabutin and dolutegravir: A population pharmacokinetic model.
- Published in:
- British Journal of Clinical Pharmacology, 2023, v. 89, n. 3, p. 1216, doi. 10.1111/bcp.15604
- By:
- Publication type:
- Article
Population pharmacokinetics of esomeprazole in patients with preterm preeclampsia.
- Published in:
- British Journal of Clinical Pharmacology, 2022, v. 88, n. 10, p. 4639, doi. 10.1111/bcp.15416
- By:
- Publication type:
- Article
Constructing a representative in‐silico population for paediatric simulations: Application to HIV‐positive African children.
- Published in:
- British Journal of Clinical Pharmacology, 2021, v. 87, n. 7, p. 2847, doi. 10.1111/bcp.14694
- By:
- Publication type:
- Article
Population pharmacokinetics of vancomycin in obesity: Finding the optimal dose for (morbidly) obese individuals.
- Published in:
- British Journal of Clinical Pharmacology, 2020, v. 86, n. 2, p. 303, doi. 10.1111/bcp.14144
- By:
- Publication type:
- Article
A Prospective Clinical Study Characterizing the Influence of Morbid Obesity on the Pharmacokinetics of Gentamicin: Towards Individualized Dosing in Obese Patients.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Clinical Pharmacokinetics and Pharmacodynamics of Micafungin.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Population pharmacokinetics of tenofovir given as either tenofovir disoproxil fumarate or tenofovir alafenamide in an African population.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2023, v. 12, n. 6, p. 821, doi. 10.1002/psp4.12955
- By:
- Publication type:
- Article
TWICE DAILY 50 MG DOLUTEGRAVIR IN TUBERCULOSIS-HIV COINFECTED CHILDREN 20-35 KG.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 331
- By:
- Publication type:
- Article
Total bodyweight and sex both drive pharmacokinetic variability of fluconazole in obese adults.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Dolutegravir pharmacokinetics during co-administration with either artemether/lumefantrine or artesunate/amodiaquine.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Implications for IV posaconazole dosing in the era of obesity.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Pharmacokinetics and probability of target attainment for micafungin in normal-weight and morbidly obese adults.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Isavuconazole susceptibility of clinical Aspergillus fumigatus isolates and feasibility of isavuconazole dose escalation to treat isolates with elevated MICs.
- Published in:
- 2018
- By:
- Publication type:
- journal article